KRAS and breast neoplasm: While the mechanism seems to vary between tissues, the connection between increased Ras/MAPK activity and MDSC recruitment appears to be conserved, because our data suggest that MEK activation downstream of oncogenic KRAS drives MDSC recruitment to breast tumors.